|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.01/--
|
企業價值
261.63M
|
資產負債 |
每股賬面淨值
6.87
|
現金流量 |
現金流量率
--
|
損益表 |
收益
0
|
每股收益
0.07
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/17 02:39 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. |